Antivirals
|
|
Your reliable supplier of generic medications.
|
|
|
Hi.
just want to say thanks for your promt and efficient service.. The tablets arrived well within the timeframe given.. Have passed on your
address, dont know wheather its been used or not..
Best regards... and happy St Patricks from the Irish in France..
- Kieran
Our billing is certified by:
- What’s best at beating swine flu, soap or gel?
Commuters obsessively scrub their hands with gel.
- Swine flu drug treatment will replace containment strategy
More than 150 people have been diagnosed with swine flu over the past 24 hours as the rate of infection accelerates, pushing the total number of UK cases above 1,000.
- Is the flu jab a waste of time?
On balance, probably not.
- Global flu pandemic would probably kill 62m, study says
Around 62 million people in the world are likely to die if there is a flu pandemic and more than 70,000 of those deaths will be in the UK, according to a statistical analysis published today.
- Vaccine against lethal strain of avian flu ready for human testing
A British drug company is seeking permission to conduct the first human trials of an experimental vaccine against the avian flu virus.
- Patients relapse after Gilead hepatitis C treatment - PMLiVE
Patients relapse after Gilead hepatitis C treatmentPMLiVEGS-7977 was one of the main assets behind Gilead's $10.
- Hepatitis C Now Kills More Americans Than HIV - MSN Health & Fitness
Hepatitis C Now Kills More Americans Than HIVMSN Health & FitnessCurrent treatment involves a cocktail of drugs, including antivirals and interferon, which many people cannot tolerate.
- Lower Immunity, Children More Prone To Viral Infections - Bernama
Lower Immunity, Children More Prone To Viral InfectionsBernama.
- Gilead tops table for antivirals - Pharma Times
Gilead tops table for antiviralsPharma TimesWith combined sales from the top HIV treatment on the market, Atripla, and several other drugs, Gilead Sciences leads the antiviral market, closely followed by Bristol-Myers Squibb, Roche and Merck & Co.
- Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide ... - MarketWatch (press release)
CitybizlistIdenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide .
 |
Bookmark this site |
|---|
